COMMUNIQUÉS West-GlobeNewswire

BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications
10/04/2026
Targets $81B command-and-control and video analytics markets by 2030, driven by real-time situational awareness in defense environments NETANYA, Israel and REHOVOT, Israel, April 10, 2026 (GLOBE NEWSWIRE) -- BiomX Inc [...]
Clariane annonce le succès de son offre de 500 millions d’euros d’obligations senior
10/04/2026
NE PAS DIFFUSER, PUBLIER OU DISTRIBUER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE, AU CANADA, AU JAPON OU EN AUSTRALIE, OU DANS TOUTE AUTRE JURIDICTION OU IL EST ILLÉGAL DE DIFFUSER, DE PUBLIER OU DE [...]
Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026
10/04/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 10 April 2026 – 7 AM CEST Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026 Fagron NV invites its shareholders and holders of [...]
Orion publishes Interim Report for January–March 2026 and holds a webcast on 23 April 2026
10/04/2026
ORION CORPORATION PRESS RELEASE 10 APRIL 2026 at 9.00 EEST Orion publishes Interim Report for January–March 2026 and holds a webcast on 23 April 2026 Orion will publish Interim Report for January–March 2026 on Thursday [...]
Idorsia issues invitation to the 2026 Annual General Meeting of Shareholders
10/04/2026
Allschwil, Switzerland – April 10, 2026 Idorsia Ltd (SIX: IDIA) today issued the invitation to the upcoming Annual General Meeting (AGM) of Shareholders on behalf of the Board of Directors. The meeting to approve the [...]
Zhen-Ao Group Showcases Core 5'-Nucleotide Breakthroughs in Cambridge, Illuminating a Chinese Path for Global Technology-Driven Anti-Aging
10/04/2026
Cambridge, UK, April 10, 2026 (GLOBE NEWSWIRE) -- On April 8th local time in the UK, the international academic conference Frontiers in Aging, Longevity and Regeneration was held at the University of Cambridge. Jointly [...]
TRICARE Now Covers Online Therapy in New York — $0 Copay for Active-Duty Families Through MMHC
10/04/2026
Manhattan Mental Health Counseling becomes an in-network TRICARE provider for New York, accepting TRICARE Select and Reserve Select for virtual therapy at Fort Hamilton, Fort Drum, West Point, Camp Smith, and statewide [...]
Vita Smart Cup Massager Claims Evaluated: 2026 Report on Suction Therapy, Red Light Technology, and What Consumers Should Know Before Buying
10/04/2026
A 2026 informational report examining Vita Smart Cup Massager's marketing claims, device specifications not disclosed on the product page, cupping and red light research context, return policy fine print, and key [...]
Best ACV Gummies Claims Evaluated: What Ingredient Labels Actually Disclose vs. What Marketing Pages Emphasize — 2026 Consumer Transparency Update
10/04/2026
A 2026 informational release covering what the Leanzene BHB + apple cider vinegar gummy label discloses, where published ingredient research supports category-level claims at studied dosages, how proprietary blend [...]
FDA Accepts NDA for TLX101-Px (Pixclara®)
10/04/2026
MELBOURNE, Australia and INDIANAPOLIS, April 10, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the United States (U.S.) Food and Drug Administration (FDA) [...]
Extendicare Announces $450 Million Inaugural Offering of Investment Grade Senior Unsecured Notes
09/04/2026
Not for distribution to U.S. news wire services or dissemination in the United States. MARKHAM, Ontario, April 09, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“ Extendicare ” or the “ Company ”) (TSX: EXE) announced [...]
Solana Company (NASDAQ: HSDT) Appoints Madelene Gani as Chief Operating Officer and Deputy CFO to Lead Next Phase of Growth
09/04/2026
A veteran architect of Gemini’s Asia Pacific expansion, Ms. Gani joins to lead institutional buildout as Solana Company executes on its strategy to drive yield expansion, enhance revenue generation, advance business [...]
Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting
09/04/2026
WEST CHESTER, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological [...]
LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference
09/04/2026
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar [...]
Certara to Report First Quarter 2026 Financial Results on May 11th, 2026
09/04/2026
RADNOR, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the first quarter of 2026 [...]
PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026
09/04/2026
SAN JOSE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions [...]
Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth
09/04/2026
Board member and Interim CEO Mani Mohindru, PhD, named President and Chief Executive Officer Appoints industry veterans Josh Muntner as Chief Financial Officer and Ajay Aggarwal, MD, MBA, as Chief Operating Officer SAN [...]
Dental Care of Stamford Challenges the Myths Holding Stamford Residents Back from the Smile They Want
09/04/2026
A new patient resource from a leading cosmetic dentist in Stamford, CT addresses the fears, misconceptions, and outdated beliefs that prevent adults from exploring modern cosmetic dentistry options. STAMFORD, CT, April [...]
Sobi reçoit l’autorisation par Santé Canada pour EMPAVELIMD (pegcétacoplan) dans le traitement de la GC3 et de la GNMP-CI primitive.
09/04/2026
EMPAVELI MD (pegcétacoplan) est le premier traitement autorisé dans le traitement des patients adultes et pédiatriques de 12 ans et plus atteints de glomérulopathie à dépôts de C3 (GC3) ou de glomérulonéphrite [...]

Pages